![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Pros and Cons of Boosted PI Monotherapy
|
|
|
Reported by Jules Levin
EACS Cologne Nov 11-14 2009
Presented in an oral talk by Dr. Jose R Arribas alter the several oral slide presentations on PI monotherapy
HIV UNIT
![image002.gif](../images/121109/121109-1/image002.gif)
![image004.gif](../images/121109/121109-1/image004.gif)
XV WAC 2004 MoOrB1057. 4th IAS 2007 WEPEB034. J Infect Dis. 2008 15;198:234. JAIDS 2005;40:280-287. AIDS. 2008;11:F1-9. XVI IAC 2006; #TUAB0102. EACS 2009 PS4/5 .J Infect Dis. 2009 15;199:866. AIDS 2007; 21:1309-1315. JAIDS 2007;44:417. EACS 2009 PS4/6. 5th IAS 2009 AIDS 2009 (in press)
![image006.gif](../images/121109/121109-1/image006.gif)
![image008.gif](../images/121109/121109-1/image008.gif)
Arribas JR. et al., 11th EACS, Madrid, 2007, # PS3/1
Systematic review of boosted PI monotherapy
![image010.gif](../images/121109/121109-1/image010.gif)
Bierman WF. AIDS 2009, 22:1-13
![image012.gif](../images/121109/121109-1/image012.gif)
![image014.gif](../images/121109/121109-1/image014.gif)
Pulido F et al. AIDS. 2008 Jan 11;22(2):F1-9.
![image016.gif](../images/121109/121109-1/image016.gif)
![image018.gif](../images/121109/121109-1/image018.gif)
![image020.gif](../images/121109/121109-1/image020.gif)
![image022.gif](../images/121109/121109-1/image022.gif)
Arribas JR. et al., 11th EACS, Madrid, 2007, # PS3/1 OK04
Single Genome Sequencing Analyisis. OK04
![image024.gif](../images/121109/121109-1/image024.gif)
Mckinnon J et al. XVII International HIV Drug Resistance Workshop. Sitges Abstract #80
Comparison of Suppressed HIV RNA levels between Treatment Arms by Study Week
![image026.gif](../images/121109/121109-1/image026.gif)
McKinnon J et al. AIDS 2006 28;20:2331-5
![image028.gif](../images/121109/121109-1/image028.gif)
OK04: Risk factors for loss of virological suppression
![image030.gif](../images/121109/121109-1/image030.gif)
Pulido F. Antivir Ther. 2009;14:195-201
Lopinavir monotherapy and CSF replication
![image032.gif](../images/121109/121109-1/image032.gif)
Yeh et al. CROI 2007
![image034.gif](../images/121109/121109-1/image034.gif)
![image036.gif](../images/121109/121109-1/image036.gif)
Canestri A et al. CROI 2009. # 484ª
![image038.gif](../images/121109/121109-1/image038.gif)
![image040.gif](../images/121109/121109-1/image040.gif)
Yeh et al. 11th EACS. 2007
![image042.gif](../images/121109/121109-1/image042.gif)
Cameron DW et al., 14th CROI, Los Angeles, February 2007, Oral#44LB M03-613
![image044.gif](../images/121109/121109-1/image044.gif)
Arribas JR. GESIDA 2009. Abstract PO071
![image046.gif](../images/121109/121109-1/image046.gif)
![image048.gif](../images/121109/121109-1/image048.gif)
EACS Guidelines 2009.
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|